Alternatives to Jazz Pharmaceuticals

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Engineering scalable gene therapies for broader patient populations.

Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A global leader in clinical pharmacology and bioanalytical sciences.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Pioneering vision restoration therapies for severe retinal degenerations.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Empowering pharmaceutical researchers with advanced molecular understanding.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Enzyme-based technology to break down alcohol in the stomach.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

AI-powered knowledge discovery for life sciences.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Developing oral small molecule medicines for immunological and chronic diseases.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing highly targeted, small molecule medicines.

Revolutionizing genomic analysis with innovative sequencing technology.

Advancing next-generation mRNA medicines.

AI-powered antibody discovery platform.

A pharmaceutical company focused on developing long-acting injectable medicines.